These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29260458)

  • 1. The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.
    Buoli M; Serati M; Botturi A; Altamura AC
    Drugs R D; 2018 Mar; 18(1):1-5. PubMed ID: 29260458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of thrombocytopenia in psychiatric patients taking valproate.
    Trannel TJ; Ahmed I; Goebert D
    Am J Psychiatry; 2001 Jan; 158(1):128-30. PubMed ID: 11136646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperammonia, hypoglycemia and thrombocytopenia in a newborn after materanl treatment with valproate].
    Bruel H; Chabrolle JP; Amusini P; Levesque L; Iskandar K; Poinsot J
    Arch Pediatr; 2001 Apr; 8(4):446-7. PubMed ID: 11339140
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal pulmonary hemorrhage during high-dose valproate monotherapy.
    Sleiman C; Raffy O; Roué C; Mal H
    Chest; 2000 Feb; 117(2):613. PubMed ID: 10669721
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproic acid and thrombocytopenia: cross-sectional study.
    Ko CH; Kong CK; Tse PW
    Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia associated with sodium valproate treatment.
    Neophytides AN; Nutt JG; Lodish JR
    Ann Neurol; 1979 Apr; 5(4):389-90. PubMed ID: 375808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)].
    Loisseau P; Martínez-Lage JM
    Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
    Kaufman KR; Gerner R
    Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A; Katsarou E; Voudris K; Garoufi A
    Epilepsia; 2007 Jan; 48(1):205-6. PubMed ID: 17241231
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin.
    Anderson GD; Lin Y; Temkin NR; Fischer JH; Winn HR
    Ann Pharmacother; 2000 Jun; 34(6):697-702. PubMed ID: 10860128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of valproate on bone mineral density in adult epileptic patients.
    Boluk A; Guzelipek M; Savli H; Temel I; Ozişik HI; Kaygusuz A
    Pharmacol Res; 2004 Jul; 50(1):93-7. PubMed ID: 15082034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate and thrombocytopenia.
    Miyake S; Honda K; Kimura S; Ike Y
    Brain Dev; 1979; 1(4):319-22. PubMed ID: 121951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haematological disturbances during long-term valproate therapy.
    Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
    Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium valproate and thrombocytopenia.
    Hoffman LM
    Can Med Assoc J; 1982 Feb; 126(4):358-9. PubMed ID: 6802479
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of thrombocytopenia with antiplatelet autoantibody after sodium valproate administration--with statistical analysis of 33 cases administrated sodium valproate].
    Terui T; Ktda K; Mitani T; Terada S; Kure T; Takamura H; Hirayama M; Niitsu Y; Nakazawa O
    Rinsho Ketsueki; 1987 Jun; 28(6):865-71. PubMed ID: 3118077
    [No Abstract]   [Full Text] [Related]  

  • 20. Hematologic toxicity of sodium valproate.
    Acharya S; Bussel JB
    J Pediatr Hematol Oncol; 2000; 22(1):62-5. PubMed ID: 10695824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.